We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Chemistry Analyzer for Small to Midsize Labs Does Precision Sampling

By LabMedica International staff writers
Posted on 23 Jul 2009
An advanced chemistry analyzer system optimizes workflow and enhances productivity in clinical laboratories. More...


Building on the success of its predecessor, the AU400e, the new AU480 minimizes sample volume requirements and features new intuitive GUI and master curve calibration. The AU480 is the ideal main analyzer for small to medium-sized laboratories due to its throughput of up to 800 tests per hour with ISE, and is simultaneously programmable for 63 different analytes. It can also be used as a special chemistry or STAT analyzer in large laboratories.

High-precision sampling, as little as 1 µl, makes the AU480 system ideal for neonatal, pediatric, and geriatric testing. Computer-controlled sample and reagent dispensing, in combination with clot detection and crash prevention, are added safety features of the AU480, resulting in unique system reliability.

The AU480 system accommodates up to 80 samples in racks and 22 in the STAT wheel. Different tube sizes may be mixed within the linear racks and loaded continuously. Serum indices (hemolysis, icterus, lipemia) can also be automatically checked.

Olympus Diagnostic Systems (Center Valley, PA, USA) diagnostic systems reagents for the AU480 are designed to match the requirements and features of the analyzer for optimum performance. Master curve reagents have 2-Dimension (2D) barcodes to maximize productivity and reduce the potential for errors in the laboratory.

The Olympus AU480 is standardized to fit seamlessly within the full line of Olympus AU-Series chemistry analyzers. All offer the same reagents, calibrators, controls, consumables, and parts; the same results and reference ranges; and the same test menu.

Olympus Diagnostic Systems provides solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physicians' office labs, veterinary labs, and pharmaceutical labs.

Related Links:

Olympus Diagnostic Systems




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.